Page last updated: 2024-11-01

omeprazole and Parotid Diseases

omeprazole has been researched along with Parotid Diseases in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Parotid Diseases: Diseases involving the PAROTID GLAND.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pino Rivero, V1
Trinidad Ramos, G1
González Palomino, A1
Pantoja Hernández, CG1
Pardo Romero, G1
Carrasco Claver, F1
Blasco Huelva, A1

Other Studies

1 other study available for omeprazole and Parotid Diseases

ArticleYear
[Parotid phlegmon with involvement of both lobes. Report of a case].
    Anales otorrinolaringologicos ibero-americanos, 2006, Volume: 33, Issue:4

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti

2006